INS and breast cancer: Nevertheless, further studies are warranted to determine whether metformin may prevent BC motility also via other mechanisms, for instance interfering with recently-identified targets of insulin signaling like the actin filament cross-linking protein filamin-A (FLNA) [114], which has been implicated in the growth and metastatic spread of BC and other hormone-dependent tumors [114–118].